Abstract:Infection of pregnant women by Zika virus (ZIKV) is associated with severe neurodevelopmental defects in newborns through poorly defined mechanisms. Here, we established a zebrafish in vivo model of ZIKV infection to circumvent limitations of existing mammalian models. Leveraging the unique tractability of this system, we gained unprecedented access to the ZIKV-infected brain at early developmental stages. The infection of zebrafish larvae with ZIKV phenocopied the disease in mammals including a reduced head area and neural progenitor cells (NPC) infection and depletion. Moreover, transcriptomic analyses of NPCs isolated from ZIKV-infected embryos revealed a distinct dysregulation of genes involved in survival and neuronal differentiation, including downregulation of the expression of the glutamate transporter vglut1 , resulting in an altered glutamatergic network in the brain. Mechanistically, ectopic expression of ZIKV protein NS4A in the larvae recapitulated the morphological defects observed in infected animals, identifying NS4A as a key determinant of neurovirulence and a promising antiviral target for developing therapies. Infections with Zika virus (ZIKV) constitute a major global public health concern worldwide. Indeed, infection of pregnant women can induce severe defects of the fetal brain and, eventually, microcephaly in the infant. Most importantly, no antiviral therapies or vaccines against ZIKV are currently available, as we poorly understand how the disease develops. Addressing these questions in mammalian models is highly challenging. Here, we report an alternative in vivo model of ZIKV infection based on zebrafish which circumvents limitations of existing models. Leveraging the unique tractability of this system, we gained unprecedented access to the ZIKV-infected brain during early developmental stages at the tissue, cell and molecular levels. The infection of zebrafish larvae with ZIKV phenocopied the disease in mammals including, a reduced head area and neural progenitor cells (NPC) infection and depletion. This correlated with a transcriptomic reprogramming of NPCs and alterations of the excitatory glutamatergic neuronal networks. Furthermore, we identified ZIKV NS4A as a key determinant of neuropathogenesis, supporting that this viral protein constitutes a promising antiviral target for developing therapies.

Recent Advances in Animal Models of Zika Virus Infection

Progress in animal models of Zika virus infection

Zika Virus Infection Induces Glycometabolic Disorder in Northern Pig-Tailed Macaques

From Mosquito Bites to Sexual Transmission: Evaluating Mouse Models of Zika Virus Infection

Vertical Transmission of the Zika Virus Causes Neurological Disorders in Mouse Offspring

A Susceptible Mouse Model for Zika Virus Infection

Advance in Zika Virus Infection-Related Myelitis

A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses

The mechanisms of Zika virus-induced neuropathogenesis

Effective Suckling C57bl/6, Kunming, and Balb/C Mouse Models with Remarkable Neurological Manifestation for Zika Virus Infection

Advances in Zika Virus Research: Stem Cell Models, Challenges, and Opportunities

Zika Virus Neuropathogenesis-Research and Understanding

An update on preclinical pregnancy models of Zika virus infection for drug and vaccine discovery

Zika (PRVABC59) Infection Is Associated with T cell Infiltration and Neurodegeneration in CNS of Immunocompetent Neonatal C57Bl/6 Mice

Understanding the Tissue Specificity of ZIKV Infection in Various Animal Models for Vaccine Development

Translational Model of Zika Virus Disease in Baboons

A zebrafish-based in vivo model of Zika virus infection unveils alterations of the glutamatergic neuronal development and NS4A as a key viral determinant of neuropathogenesis

Zika virus: The transboundary pathogen from mosquito and updates.

Characterization of Lethal Zika Virus Infection in AG129 Mice

Recent progresses and remaining challenges for the detection of Zika virus

An Immunocompetent Mouse Model of Zika Virus Infection.